Global Nuclear Medicine or Radiopharmaceuticals Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Nuclear Medicine or Radiopharmaceuticals market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Nuclear Medicine or Radiopharmaceuticals market are covered in Chapter 9:
Jubilant Life Sciences
Advanced Accelerator Applications
Cardinal Health
Curium Pharma
China Isotope & Radiation Corporation
GE Healthcare
Nihon Medi-Physics Co. Ltd.
Lantheus Medical Imaging
In Chapter 5 and Chapter 7.3, based on types, the Nuclear Medicine or Radiopharmaceuticals market from 2017 to 2027 is primarily split into:
SPECT Radiopharmaceuticals (Diagnostics)
PET Radiopharmaceuticals (Diagnostics)
Beta Emitters (Therapeutics)
Alpha Emitters (Therapeutics)
Brachytherapy Isotopes (Therapeutics)
In Chapter 6 and Chapter 7.4, based on applications, the Nuclear Medicine or Radiopharmaceuticals market from 2017 to 2027 covers:
Oncology
Cardiology
Thyroid
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Nuclear Medicine or Radiopharmaceuticals market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Nuclear Medicine or Radiopharmaceuticals Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Nuclear Medicine or Radiopharmaceuticals market are covered in Chapter 9:
Jubilant Life Sciences
Advanced Accelerator Applications
Cardinal Health
Curium Pharma
China Isotope & Radiation Corporation
GE Healthcare
Nihon Medi-Physics Co. Ltd.
Lantheus Medical Imaging
In Chapter 5 and Chapter 7.3, based on types, the Nuclear Medicine or Radiopharmaceuticals market from 2017 to 2027 is primarily split into:
SPECT Radiopharmaceuticals (Diagnostics)
PET Radiopharmaceuticals (Diagnostics)
Beta Emitters (Therapeutics)
Alpha Emitters (Therapeutics)
Brachytherapy Isotopes (Therapeutics)
In Chapter 6 and Chapter 7.4, based on applications, the Nuclear Medicine or Radiopharmaceuticals market from 2017 to 2027 covers:
Oncology
Cardiology
Thyroid
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Nuclear Medicine or Radiopharmaceuticals market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Nuclear Medicine or Radiopharmaceuticals Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET OVERVIEW
1.1 Product Overview and Scope of Nuclear Medicine or Radiopharmaceuticals Market
1.2 Nuclear Medicine or Radiopharmaceuticals Market Segment by Type
1.2.1 Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Nuclear Medicine or Radiopharmaceuticals Market Segment by Application
1.3.1 Nuclear Medicine or Radiopharmaceuticals Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Nuclear Medicine or Radiopharmaceuticals Market, Region Wise (2017-2027)
1.4.1 Global Nuclear Medicine or Radiopharmaceuticals Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.3 Europe Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.4 China Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.5 Japan Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.6 India Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.8 Latin America Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.5 Global Market Size of Nuclear Medicine or Radiopharmaceuticals (2017-2027)
1.5.1 Global Nuclear Medicine or Radiopharmaceuticals Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Nuclear Medicine or Radiopharmaceuticals Market
2 INDUSTRY OUTLOOK
2.1 Nuclear Medicine or Radiopharmaceuticals Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Nuclear Medicine or Radiopharmaceuticals Market Drivers Analysis
2.4 Nuclear Medicine or Radiopharmaceuticals Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Nuclear Medicine or Radiopharmaceuticals Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development
3 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET LANDSCAPE BY PLAYER
3.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Share by Player (2017-2022)
3.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share by Player (2017-2022)
3.3 Global Nuclear Medicine or Radiopharmaceuticals Average Price by Player (2017-2022)
3.4 Global Nuclear Medicine or Radiopharmaceuticals Gross Margin by Player (2017-2022)
3.5 Nuclear Medicine or Radiopharmaceuticals Market Competitive Situation and Trends
3.5.1 Nuclear Medicine or Radiopharmaceuticals Market Concentration Rate
3.5.2 Nuclear Medicine or Radiopharmaceuticals Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.5 Europe Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.6 China Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.7 Japan Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.8 India Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.9 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.10 Latin America Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.11 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
5 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Market Share by Type (2017-2022)
5.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share by Type (2017-2022)
5.3 Global Nuclear Medicine or Radiopharmaceuticals Price by Type (2017-2022)
5.4 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2017-2022)
5.4.2 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2017-2022)
5.4.3 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of Beta Emitters (Therapeutics) (2017-2022)
5.4.4 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of Alpha Emitters (Therapeutics) (2017-2022)
5.4.5 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2017-2022)
6 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
6.1 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Market Share by Application (2017-2022)
6.2 Global Nuclear Medicine or Radiopharmaceuticals Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Oncology (2017-2022)
6.3.2 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Cardiology (2017-2022)
6.3.3 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Thyroid (2017-2022)
7 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET FORECAST (2022-2027)
7.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Nuclear Medicine or Radiopharmaceuticals Price and Trend Forecast (2022-2027)
7.2 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2022-2027)
7.3.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2022-2027)
7.3.3 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of Beta Emitters (Therapeutics) (2022-2027)
7.3.4 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of Alpha Emitters (Therapeutics) (2022-2027)
7.3.5 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2022-2027)
7.4 Global Nuclear Medicine or Radiopharmaceuticals Consumption Forecast by Application (2022-2027)
7.4.1 Global Nuclear Medicine or Radiopharmaceuticals Consumption Value and Growth Rate of Oncology(2022-2027)
7.4.2 Global Nuclear Medicine or Radiopharmaceuticals Consumption Value and Growth Rate of Cardiology(2022-2027)
7.4.3 Global Nuclear Medicine or Radiopharmaceuticals Consumption Value and Growth Rate of Thyroid(2022-2027)
7.5 Nuclear Medicine or Radiopharmaceuticals Market Forecast Under COVID-19
8 NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Nuclear Medicine or Radiopharmaceuticals Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Nuclear Medicine or Radiopharmaceuticals Analysis
8.6 Major Downstream Buyers of Nuclear Medicine or Radiopharmaceuticals Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Nuclear Medicine or Radiopharmaceuticals Industry
9 PLAYERS PROFILES
9.1 Jubilant Life Sciences
9.1.1 Jubilant Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.1.3 Jubilant Life Sciences Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Advanced Accelerator Applications
9.2.1 Advanced Accelerator Applications Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.2.3 Advanced Accelerator Applications Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Cardinal Health
9.3.1 Cardinal Health Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.3.3 Cardinal Health Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Curium Pharma
9.4.1 Curium Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.4.3 Curium Pharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 China Isotope & Radiation Corporation
9.5.1 China Isotope & Radiation Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.5.3 China Isotope & Radiation Corporation Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 GE Healthcare
9.6.1 GE Healthcare Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.6.3 GE Healthcare Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Nihon Medi-Physics Co. Ltd.
9.7.1 Nihon Medi-Physics Co. Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.7.3 Nihon Medi-Physics Co. Ltd. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Lantheus Medical Imaging
9.8.1 Lantheus Medical Imaging Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.8.3 Lantheus Medical Imaging Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Nuclear Medicine or Radiopharmaceuticals Market
1.2 Nuclear Medicine or Radiopharmaceuticals Market Segment by Type
1.2.1 Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Nuclear Medicine or Radiopharmaceuticals Market Segment by Application
1.3.1 Nuclear Medicine or Radiopharmaceuticals Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Nuclear Medicine or Radiopharmaceuticals Market, Region Wise (2017-2027)
1.4.1 Global Nuclear Medicine or Radiopharmaceuticals Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.3 Europe Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.4 China Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.5 Japan Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.6 India Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.8 Latin America Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Status and Prospect (2017-2027)
1.5 Global Market Size of Nuclear Medicine or Radiopharmaceuticals (2017-2027)
1.5.1 Global Nuclear Medicine or Radiopharmaceuticals Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Nuclear Medicine or Radiopharmaceuticals Market
2 INDUSTRY OUTLOOK
2.1 Nuclear Medicine or Radiopharmaceuticals Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Nuclear Medicine or Radiopharmaceuticals Market Drivers Analysis
2.4 Nuclear Medicine or Radiopharmaceuticals Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Nuclear Medicine or Radiopharmaceuticals Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development
3 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET LANDSCAPE BY PLAYER
3.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Share by Player (2017-2022)
3.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share by Player (2017-2022)
3.3 Global Nuclear Medicine or Radiopharmaceuticals Average Price by Player (2017-2022)
3.4 Global Nuclear Medicine or Radiopharmaceuticals Gross Margin by Player (2017-2022)
3.5 Nuclear Medicine or Radiopharmaceuticals Market Competitive Situation and Trends
3.5.1 Nuclear Medicine or Radiopharmaceuticals Market Concentration Rate
3.5.2 Nuclear Medicine or Radiopharmaceuticals Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.5 Europe Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.6 China Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.7 Japan Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.8 India Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.9 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.10 Latin America Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
4.11 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Under COVID-19
5 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Market Share by Type (2017-2022)
5.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Market Share by Type (2017-2022)
5.3 Global Nuclear Medicine or Radiopharmaceuticals Price by Type (2017-2022)
5.4 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2017-2022)
5.4.2 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2017-2022)
5.4.3 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of Beta Emitters (Therapeutics) (2017-2022)
5.4.4 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of Alpha Emitters (Therapeutics) (2017-2022)
5.4.5 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2017-2022)
6 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
6.1 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Market Share by Application (2017-2022)
6.2 Global Nuclear Medicine or Radiopharmaceuticals Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Oncology (2017-2022)
6.3.2 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Cardiology (2017-2022)
6.3.3 Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Thyroid (2017-2022)
7 GLOBAL NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET FORECAST (2022-2027)
7.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Nuclear Medicine or Radiopharmaceuticals Price and Trend Forecast (2022-2027)
7.2 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2022-2027)
7.3.2 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2022-2027)
7.3.3 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of Beta Emitters (Therapeutics) (2022-2027)
7.3.4 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of Alpha Emitters (Therapeutics) (2022-2027)
7.3.5 Global Nuclear Medicine or Radiopharmaceuticals Revenue and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2022-2027)
7.4 Global Nuclear Medicine or Radiopharmaceuticals Consumption Forecast by Application (2022-2027)
7.4.1 Global Nuclear Medicine or Radiopharmaceuticals Consumption Value and Growth Rate of Oncology(2022-2027)
7.4.2 Global Nuclear Medicine or Radiopharmaceuticals Consumption Value and Growth Rate of Cardiology(2022-2027)
7.4.3 Global Nuclear Medicine or Radiopharmaceuticals Consumption Value and Growth Rate of Thyroid(2022-2027)
7.5 Nuclear Medicine or Radiopharmaceuticals Market Forecast Under COVID-19
8 NUCLEAR MEDICINE OR RADIOPHARMACEUTICALS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Nuclear Medicine or Radiopharmaceuticals Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Nuclear Medicine or Radiopharmaceuticals Analysis
8.6 Major Downstream Buyers of Nuclear Medicine or Radiopharmaceuticals Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Nuclear Medicine or Radiopharmaceuticals Industry
9 PLAYERS PROFILES
9.1 Jubilant Life Sciences
9.1.1 Jubilant Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.1.3 Jubilant Life Sciences Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Advanced Accelerator Applications
9.2.1 Advanced Accelerator Applications Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.2.3 Advanced Accelerator Applications Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Cardinal Health
9.3.1 Cardinal Health Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.3.3 Cardinal Health Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Curium Pharma
9.4.1 Curium Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.4.3 Curium Pharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 China Isotope & Radiation Corporation
9.5.1 China Isotope & Radiation Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.5.3 China Isotope & Radiation Corporation Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 GE Healthcare
9.6.1 GE Healthcare Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.6.3 GE Healthcare Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Nihon Medi-Physics Co. Ltd.
9.7.1 Nihon Medi-Physics Co. Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.7.3 Nihon Medi-Physics Co. Ltd. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Lantheus Medical Imaging
9.8.1 Lantheus Medical Imaging Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Nuclear Medicine or Radiopharmaceuticals Product Profiles, Application and Specification
9.8.3 Lantheus Medical Imaging Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Nuclear Medicine or Radiopharmaceuticals Product Picture
Table Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and CAGR (%) Comparison by Type
Table Nuclear Medicine or Radiopharmaceuticals Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume by Player (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Share by Player (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Share by Player in 2021
Table Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) by Player (2017-2022)
Table Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Player (2017-2022)
Table Nuclear Medicine or Radiopharmaceuticals Price by Player (2017-2022)
Table Nuclear Medicine or Radiopharmaceuticals Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Region Wise (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share, Region Wise in 2021
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD), Region Wise (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share, Region Wise (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share, Region Wise (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share, Region Wise in 2021
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume by Type (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share by Type (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share by Type in 2021
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) by Type (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Type in 2021
Table Nuclear Medicine or Radiopharmaceuticals Price by Type (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of Beta Emitters (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Beta Emitters (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of Alpha Emitters (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Alpha Emitters (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption by Application (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Market Share by Application (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Revenue Market Share by Application (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Oncology (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Cardiology (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Thyroid (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Price and Trend Forecast (2022-2027)
Figure USA Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Price Forecast, by Type
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Beta Emitters (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Beta Emitters (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Alpha Emitters (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Alpha Emitters (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2022-2027)
Table Global Nuclear Medicine or Radiopharmaceuticals Market Consumption Forecast, by Application
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Market Share Forecast, by Application
Table Global Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) Forecast, by Application
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share Forecast, by Application
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption Value (Million USD) and Growth Rate of Cardiology (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption Value (Million USD) and Growth Rate of Thyroid (2022-2027)
Figure Nuclear Medicine or Radiopharmaceuticals Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Jubilant Life Sciences Profile
Table Jubilant Life Sciences Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Jubilant Life Sciences Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Jubilant Life Sciences Revenue (Million USD) Market Share 2017-2022
Table Advanced Accelerator Applications Profile
Table Advanced Accelerator Applications Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Advanced Accelerator Applications Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Advanced Accelerator Applications Revenue (Million USD) Market Share 2017-2022
Table Cardinal Health Profile
Table Cardinal Health Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cardinal Health Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Cardinal Health Revenue (Million USD) Market Share 2017-2022
Table Curium Pharma Profile
Table Curium Pharma Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Curium Pharma Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Curium Pharma Revenue (Million USD) Market Share 2017-2022
Table China Isotope & Radiation Corporation Profile
Table China Isotope & Radiation Corporation Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure China Isotope & Radiation Corporation Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure China Isotope & Radiation Corporation Revenue (Million USD) Market Share 2017-2022
Table GE Healthcare Profile
Table GE Healthcare Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GE Healthcare Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure GE Healthcare Revenue (Million USD) Market Share 2017-2022
Table Nihon Medi-Physics Co. Ltd. Profile
Table Nihon Medi-Physics Co. Ltd. Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nihon Medi-Physics Co. Ltd. Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Nihon Medi-Physics Co. Ltd. Revenue (Million USD) Market Share 2017-2022
Table Lantheus Medical Imaging Profile
Table Lantheus Medical Imaging Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lantheus Medical Imaging Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Lantheus Medical Imaging Revenue (Million USD) Market Share 2017-2022
Figure Nuclear Medicine or Radiopharmaceuticals Product Picture
Table Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and CAGR (%) Comparison by Type
Table Nuclear Medicine or Radiopharmaceuticals Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Nuclear Medicine or Radiopharmaceuticals Industry Development
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume by Player (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Share by Player (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Share by Player in 2021
Table Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) by Player (2017-2022)
Table Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Player (2017-2022)
Table Nuclear Medicine or Radiopharmaceuticals Price by Player (2017-2022)
Table Nuclear Medicine or Radiopharmaceuticals Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Region Wise (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share, Region Wise in 2021
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD), Region Wise (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share, Region Wise (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share, Region Wise (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share, Region Wise in 2021
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume by Type (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share by Type (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share by Type in 2021
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) by Type (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share by Type in 2021
Table Nuclear Medicine or Radiopharmaceuticals Price by Type (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of Beta Emitters (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Beta Emitters (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of Alpha Emitters (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Alpha Emitters (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption by Application (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Market Share by Application (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Revenue Market Share by Application (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Oncology (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Cardiology (2017-2022)
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption and Growth Rate of Thyroid (2017-2022)
Figure Global Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Price and Trend Forecast (2022-2027)
Figure USA Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Nuclear Medicine or Radiopharmaceuticals Market Sales Volume Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Sales Volume Market Share Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share Forecast, by Type
Table Global Nuclear Medicine or Radiopharmaceuticals Price Forecast, by Type
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of SPECT Radiopharmaceuticals (Diagnostics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of PET Radiopharmaceuticals (Diagnostics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Beta Emitters (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Beta Emitters (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Alpha Emitters (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Alpha Emitters (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Revenue (Million USD) and Growth Rate of Brachytherapy Isotopes (Therapeutics) (2022-2027)
Table Global Nuclear Medicine or Radiopharmaceuticals Market Consumption Forecast, by Application
Table Global Nuclear Medicine or Radiopharmaceuticals Consumption Market Share Forecast, by Application
Table Global Nuclear Medicine or Radiopharmaceuticals Market Revenue (Million USD) Forecast, by Application
Table Global Nuclear Medicine or Radiopharmaceuticals Revenue Market Share Forecast, by Application
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption Value (Million USD) and Growth Rate of Cardiology (2022-2027)
Figure Global Nuclear Medicine or Radiopharmaceuticals Consumption Value (Million USD) and Growth Rate of Thyroid (2022-2027)
Figure Nuclear Medicine or Radiopharmaceuticals Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Jubilant Life Sciences Profile
Table Jubilant Life Sciences Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Jubilant Life Sciences Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Jubilant Life Sciences Revenue (Million USD) Market Share 2017-2022
Table Advanced Accelerator Applications Profile
Table Advanced Accelerator Applications Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Advanced Accelerator Applications Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Advanced Accelerator Applications Revenue (Million USD) Market Share 2017-2022
Table Cardinal Health Profile
Table Cardinal Health Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cardinal Health Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Cardinal Health Revenue (Million USD) Market Share 2017-2022
Table Curium Pharma Profile
Table Curium Pharma Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Curium Pharma Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Curium Pharma Revenue (Million USD) Market Share 2017-2022
Table China Isotope & Radiation Corporation Profile
Table China Isotope & Radiation Corporation Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure China Isotope & Radiation Corporation Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure China Isotope & Radiation Corporation Revenue (Million USD) Market Share 2017-2022
Table GE Healthcare Profile
Table GE Healthcare Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GE Healthcare Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure GE Healthcare Revenue (Million USD) Market Share 2017-2022
Table Nihon Medi-Physics Co. Ltd. Profile
Table Nihon Medi-Physics Co. Ltd. Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nihon Medi-Physics Co. Ltd. Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Nihon Medi-Physics Co. Ltd. Revenue (Million USD) Market Share 2017-2022
Table Lantheus Medical Imaging Profile
Table Lantheus Medical Imaging Nuclear Medicine or Radiopharmaceuticals Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lantheus Medical Imaging Nuclear Medicine or Radiopharmaceuticals Sales Volume and Growth Rate
Figure Lantheus Medical Imaging Revenue (Million USD) Market Share 2017-2022
